Millennium Management LLC Has $519,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC)

Millennium Management LLC reduced its holdings in Celcuity Inc. (NASDAQ:CELC) by 74.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 39,660 shares of the company’s stock after selling 113,721 shares during the quarter. Millennium Management LLC owned approximately 0.11% of Celcuity worth $519,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Summit Investment Advisors Inc. lifted its stake in shares of Celcuity by 49.5% in the fourth quarter. Summit Investment Advisors Inc. now owns 3,421 shares of the company’s stock valued at $45,000 after buying an additional 1,132 shares in the last quarter. Aquatic Capital Management LLC purchased a new position in Celcuity during the fourth quarter valued at approximately $50,000. The Manufacturers Life Insurance Company bought a new stake in Celcuity during the fourth quarter valued at approximately $142,000. Bleakley Financial Group LLC bought a new stake in shares of Celcuity in the 4th quarter worth approximately $146,000. Finally, Trexquant Investment LP bought a new stake in Celcuity during the 4th quarter valued at $152,000. 63.33% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CELC has been the topic of a number of research analyst reports. HC Wainwright reissued a “buy” rating and set a $27.00 price objective on shares of Celcuity in a research report on Monday, May 19th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price objective on shares of Celcuity in a research note on Thursday, May 15th. Five research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $30.80.

Celcuity Trading Up 10.8%

CELC stock opened at $13.05 on Monday. The firm has a fifty day moving average price of $10.39 and a 200 day moving average price of $11.29. Celcuity Inc. has a fifty-two week low of $7.58 and a fifty-two week high of $19.77. The company has a debt-to-equity ratio of 0.65, a quick ratio of 10.36 and a current ratio of 10.35. The firm has a market cap of $494.15 million, a PE ratio of -5.00 and a beta of 0.37.

Celcuity (NASDAQ:CELC) last released its quarterly earnings data on Wednesday, May 14th. The company reported ($0.86) earnings per share for the quarter, beating the consensus estimate of ($0.95) by $0.09. Sell-side analysts anticipate that Celcuity Inc. will post -2.62 earnings per share for the current fiscal year.

Celcuity Profile

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.